Benet, I <br/><br/>
Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC).  [electronic resource] 

 -  Bone marrow transplantation  Jun 1999 
 - 1101-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1701774  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--therapy<br/>Female<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Hematopoietic Stem Cell Mobilization<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Middle Aged<br/>Risk<br/>Transplantation, Autologous